Monitor the shareholder vote on November 12, 2026. If approved, watch for the filing of a definitive business combination agreement and subsequent proxy statement for the de-SPAC vote. If not approved, expect liquidation and redemption of public shares within 10 business days.
Price Chart
Executive Summary
GP-Act III Acquisition Corp. (GPAT) is seeking shareholder approval at an extraordinary general meeting on November 12, 2026, to extend its deadline to complete a business combination from November 13, 2026 to May 8, 2027. The extension is needed to finalize negotiations for a potential business combination with an aerospace and logistics technology company developing autonomous cargo aircraft, with which it signed a non-binding term sheet on July 10, 2026. If the extension is not approved, the SPAC will liquidate and redeem its public shares at approximately $11.07 per share, and its warrants will expire worthless.
Key Facts
- GPAT is seeking to extend its business combination deadline from November 13, 2026 to May 8, 2027.
- The SPAC entered into a non-binding term sheet on July 10, 2026 with an aerospace and logistics technology company developing autonomous cargo aircraft.
- Trust Account balance as of October 26, 2026 was $99,392,076.68, with an estimated redemption price of $11.07 per share.
- Insiders (Sponsor HoldCo and initial shareholders) own 7,187,500 Class A shares (44.5%) and intend to vote FOR the extension.
- If the extension is not approved, the SPAC will liquidate and redeem public shares, with warrants expiring worthless.
- A prior extension in May 2026 resulted in 19,776,272 shares redeemed at $10.89 per share, leaving approximately $97.8 million in trust.
- The extension requires a two-thirds vote for the charter amendment and 65% for the trust agreement amendment.
- Public shareholders may elect to redeem their shares regardless of how they vote on the proposals.
Financial Impact
Trust Account holds $99,392,076.68; estimated redemption price $11.07 per share; prior redemption of 19,776,272 shares at $10.89 per share removed $215.4 million from trust.
Risk Factors
- The potential business combination may not be consummated even if the extension is approved.
- Significant redemptions could leave insufficient cash in the Trust Account to complete a business combination.
- Nasdaq may delist securities if continued listing requirements are not met after redemptions.
- The non-binding term sheet does not guarantee a definitive agreement will be reached.
- Regulatory reviews (CFIUS, foreign investment regimes) could delay or block the transaction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001213900-26-112471 |
| Document: 0001213900-26-112471-index-headers.html | 0001213900-26-112471 |
| Document: 0001213900-26-112471-index.html | 0001213900-26-112471 |
| Document: 0001213900-26-112471.txt | 0001213900-26-112471 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers